Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabeth Fenwick

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Advances in Therapy|January 8, 2022
Correction to: An Innovative Approach to Modelling the Optimal Treatment Sequence for Patients with Relapsing-Remitting Multiple Sclerosis: Implementation, Validation, and Impact of the Decision-Making ApproachMarjanne A Piena, Sonja Kroep, Claire Simons, et al.
Health Economics|March 5, 2014
Communicating the parameter uncertainty in the IQWiG efficiency frontier to decision-makersBjörn Stollenwerk, Stefan K Lhachimi, Andrew Briggs, et al.
Advances in Therapy|November 19, 2021
An Innovative Approach to Modelling the Optimal Treatment Sequence for Patients with Relapsing-Remitting Multiple Sclerosis: Implementation, Validation, and Impact of the Decision-Making ApproachMarjanne A Piena, Sonja Kroep, Claire Simons, et al.
Advances in Therapy|April 8, 2025
A Cost-Effectiveness Analysis of Abemaciclib in Combination with Adjuvant Endocrine Therapy for HR+, HER2-, Node-Positive, High-Risk Early Breast CancerAlison Davie, Sory Traoré, Waleed Badreldin, et al.
International Journal of Technology Assessment in Health Care|January 10, 2013
Transcatheter aortic valve implantation for severe aortic stenosis: the cost-effectiveness case for inoperable patients in the United KingdomAileen Murphy, Elisabeth Fenwick, William D Toff, et al.
Health Technology Assessment (Winchester, England)|September 1, 2015
The management of Otitis Media with Effusion in children with cleft palate (mOMEnt): a feasibility study and economic evaluationIain Bruce, Nicola Harman, Paula Williamson, et al.
Journal of Medical Economics|November 25, 2017
Cost-effectiveness of TYRX absorbable antibacterial envelope for prevention of cardiovascular implantable electronic device infectionGemma Kay, Elizabeth L Eby, Benedict Brown, et al.
Pharmacoeconomics|June 18, 2005
Incorporation of uncertainty in health economic modelling studiesAnthony O'Hagan, Christopher McCabe, Ron Akehurst, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 2, 2020
Value of Information Analysis for Research Decisions-An Introduction: Report 1 of the ISPOR Value of Information Analysis Emerging Good Practices Task ForceElisabeth Fenwick, Lotte Steuten, Saskia Knies, et al.
Vaccine|August 16, 2017
Adjuvant HPV vaccination for anal cancer prevention in HIV-positive men who have sex with men: The time is nowAshish A Deshmukh, Scott B Cantor, Elisabeth Fenwick, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Advances in Therapy|January 8, 2022
Correction to: An Innovative Approach to Modelling the Optimal Treatment Sequence for Patients with Relapsing-Remitting Multiple Sclerosis: Implementation, Validation, and Impact of the Decision-Making ApproachMarjanne A Piena, Sonja Kroep, Claire Simons, et al.
Health Economics|March 5, 2014
Communicating the parameter uncertainty in the IQWiG efficiency frontier to decision-makersBjörn Stollenwerk, Stefan K Lhachimi, Andrew Briggs, et al.
Advances in Therapy|November 19, 2021
An Innovative Approach to Modelling the Optimal Treatment Sequence for Patients with Relapsing-Remitting Multiple Sclerosis: Implementation, Validation, and Impact of the Decision-Making ApproachMarjanne A Piena, Sonja Kroep, Claire Simons, et al.
Advances in Therapy|April 8, 2025
A Cost-Effectiveness Analysis of Abemaciclib in Combination with Adjuvant Endocrine Therapy for HR+, HER2-, Node-Positive, High-Risk Early Breast CancerAlison Davie, Sory Traoré, Waleed Badreldin, et al.
International Journal of Technology Assessment in Health Care|January 10, 2013
Transcatheter aortic valve implantation for severe aortic stenosis: the cost-effectiveness case for inoperable patients in the United KingdomAileen Murphy, Elisabeth Fenwick, William D Toff, et al.
Health Technology Assessment (Winchester, England)|September 1, 2015
The management of Otitis Media with Effusion in children with cleft palate (mOMEnt): a feasibility study and economic evaluationIain Bruce, Nicola Harman, Paula Williamson, et al.
Journal of Medical Economics|November 25, 2017
Cost-effectiveness of TYRX absorbable antibacterial envelope for prevention of cardiovascular implantable electronic device infectionGemma Kay, Elizabeth L Eby, Benedict Brown, et al.
Pharmacoeconomics|June 18, 2005
Incorporation of uncertainty in health economic modelling studiesAnthony O'Hagan, Christopher McCabe, Ron Akehurst, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 2, 2020
Value of Information Analysis for Research Decisions-An Introduction: Report 1 of the ISPOR Value of Information Analysis Emerging Good Practices Task ForceElisabeth Fenwick, Lotte Steuten, Saskia Knies, et al.
Vaccine|August 16, 2017
Adjuvant HPV vaccination for anal cancer prevention in HIV-positive men who have sex with men: The time is nowAshish A Deshmukh, Scott B Cantor, Elisabeth Fenwick, et al.
Pageof 5